ArticleNMR in biomedicine2025
Hybrid Multidelay PCASL Acquired With Time-Encoded and Variable-TR Schemes for the Assessment of Cerebral Perfusion in Moyamoya Disease.
Article in NMR in biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Multidelay arterial spin labeling (ASL) MRI requires balancing temporal information with signal-to-noise ratio (SNR). A hybrid scheme combines the high SNR of time-encoded pseudo-continuous ASL (PCASL) with the temporal flexibility of variable-TR PCASL. The purpose of the present study was to assess the SNR and quantitative performance of the hybrid scheme by comparing it to time-encoded and variable-TR schemes for evaluating cerebral perfusion in patients with moyamoya disease. Twenty patients with moyamoya disease (8 men and 12 women, 27.6 ± 22.7 years) were scanned with 3 T MRI system. Variable-TR PCASL with 12 delays (vTR12), time-encoded PCASL with seven delays (TEnc7), and hybrid PCASL with 12 (4 × 3) delays (Hyb12) were obtained. Hyb12 and vTR12 were configured with nearly identical label duration (LD) and postlabeling delay (PLD) settings. For TEnc7, it was balanced so that the maximum LD + PLD time is the same. Time-corrected SNR (SNR
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.